Clinical Trials
63 trialsA Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines
St. James's Hospital, Ireland
PATH
VA Office of Research and Development
Savolitinib vs. Sunitinib in MET-driven PRCC.
AstraZeneca
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
H. Lee Moffitt Cancer Center and Research Institute
CysPed
University Hospital, Toulouse
Archival of Human Biological Samples in CU-Med Biobank
Chinese University of Hong Kong
ARCH
University of Colorado, Denver
Advancing Health Information Exchange (HIE) During Inter-hospital Transfer (IHT) to Improve Patient Outcomes
Brigham and Women's Hospital
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Jinling Hospital, China
Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
NiKang Therapeutics, Inc.
JAVELIN Renal 101
Pfizer
Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy
Centre of Postgraduate Medical Education
A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders
University of Alabama at Birmingham
MoveStrong
University of Waterloo
Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions
Rigshospitalet, Denmark
A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.
Guangzhou Red Pine Medical Instrument Co., Ltd.
PODRACING
University Hospital, Ghent
Observational, Retrospective, Multicenter, Nonprofit Study on the Prevalence of Renal Involvement in Pediatric Patients With Tuberous Sclerosis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
KiRi
Technical University of Munich
Variation in Drug Interactions in People With HIV (PLWH) Aged 60 Years and Older.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease
University of Michigan
REMEDY
University Health Network, Toronto
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment
Taiho Oncology, Inc.
MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults.
University of Waterloo
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sanguine Biosciences
BANN
University Medical Center Groningen
STONE
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
PURE
Population Health Research Institute
Preparing Family Caregivers to Make Medical Decisions for Their Loved Ones
Milton S. Hershey Medical Center
Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Aravive, Inc.
Parsabiv-MBD
Columbia University
AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)
Audubon Bioscience
PACEinMM-ON
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Effect of Genetic and Epigenetic Factors on the Clinical Response and Toxicity to Cisplatin Among Egyptian Non-small Cell Lung Cancer Patients
Ain Shams University
Estimation of Minimum Efficacy Daily Dose of Jarlsberg Cheese
Meddoc
PACEinMM-QC
Université de Sherbrooke
Mesenchymal Stem Cells After Renal or Liver Transplantation
University of Liege
PROTECT
Radboud University Medical Center
JAVELIN Renal 100
Pfizer
LISSE1
Centre Hospitalier Régional d'Orléans
SOROCOV
Butantan Institute
A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma
Celldex Therapeutics
eMERGE
Vanderbilt University Medical Center
ChemoRenCan
University Hospital, Bordeaux
A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Celldex Therapeutics
A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer
Celldex Therapeutics
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
Amgen
HCQIgAN
Peking Union Medical College Hospital
Renal Hypothermia During Partial Nephrectomy
Ottawa Hospital Research Institute
Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
Stanford University